ERIKSEN; Jon Amund
Patent Applications and Registrations
Patent applications and USPTO patent grants for ERIKSEN; Jon Amund.The latest application filed is for "peptides".
- ERIKSEN; Jon Amund - Porsgrunn NO
- Eriksen; Jon Amund - Oslo NO
| Patent | Date |
|---|---|
| Peptides App 20220213170 - ERIKSEN; Jon Amund | 2022-07-07 |
| Oncolytic Adenoviral Vector Expressing Peptidylarginine Deiminase And Tissue Inhibitor Of Metalloproteinase App 20220154218 - KURYK; Lukasz ; et al. | 2022-05-19 |
| Oncolytic Adenoviral Vector Expressing A Member Of The B7 Family Of Costimulatory Ligands And Ada App 20220152134 - KURYK; Lukasz ; et al. | 2022-05-19 |
| Peptide mixture Grant 10,596,239 - Eriksen | 2020-03-24 |
| Mutated Fragments Of The Ras Protein App 20190374628 - Eriksen; Jon Amund | 2019-12-12 |
| Peptide mixture Grant 10,456,457 - Eriksen Oc | 2019-10-29 |
| Peptide mixture Grant 10,335,473 - Eriksen | 2019-07-02 |
| Peptide Mixture App 20180021419 - Eriksen; Jon Amund | 2018-01-25 |
| Peptide Mixture App 20170326218 - Eriksen; Jon Amund | 2017-11-16 |
| Peptide mixture Grant 9,775,892 - Eriksen October 3, 2 | 2017-10-03 |
| Peptide vaccine comprising mutant RAS peptide and chemotherapeutic agent Grant 9,757,439 - Eriksen , et al. September 12, 2 | 2017-09-12 |
| Peptide Mixture App 20170189515 - Eriksen; Jon Amund | 2017-07-06 |
| Peptide Vaccine Comprising Mutant Ras Peptide And Chemotherapeutic Agent App 20170065694 - Eriksen; Jon Amund ; et al. | 2017-03-09 |
| Peptide Mixture App 20160331820 - ERIKSEN; Jon Amund | 2016-11-17 |
| Nonapeptide With Anti-tumour Activity App 20160176923 - Haug; Bengt Erik ; et al. | 2016-06-23 |
| Nonapeptide with anti-tumour activity Grant 9,241,968 - Haug , et al. January 26, 2 | 2016-01-26 |
| Peptides Grant 8,614,177 - Gaudernack , et al. December 24, 2 | 2013-12-24 |
| Polypeptides App 20120269858 - GAUDERNACK; Gustav ; et al. | 2012-10-25 |
| Nucleic acids encoding novel TERT polypeptides Grant 8,193,326 - Gaudernack , et al. June 5, 2 | 2012-06-05 |
| Nonapeptide With Anti-tumour Activity App 20110318364 - Haug; Bengt Erik ; et al. | 2011-12-29 |
| Peptides App 20110105721 - Gaudernack; Gustav ; et al. | 2011-05-05 |
| Peptides Grant 7,863,244 - Gaudernack , et al. January 4, 2 | 2011-01-04 |
| Antigenic peptides derived from telomerase Grant 7,794,723 - Gaudernack , et al. September 14, 2 | 2010-09-14 |
| Polypeptides App 20080187551 - Gaudernack; Gustav ; et al. | 2008-08-07 |
| Polypeptides Grant 7,375,117 - Gaudernack , et al. May 20, 2 | 2008-05-20 |
| Peptides Grant 7,192,927 - Gaudernack , et al. March 20, 2 | 2007-03-20 |
| Peptides App 20070004632 - Gaudernack; Gustav ; et al. | 2007-01-04 |
| Polypeptides App 20060194731 - Gaudernack; Gustav ; et al. | 2006-08-31 |
| Polypeptides Grant 7,078,416 - Gaudernack , et al. July 18, 2 | 2006-07-18 |
| Antigenic peptides derived from telomerase App 20060106196 - Gaudernack; Gustav ; et al. | 2006-05-18 |
| Antigenic peptides derived from telomerase Grant 7,030,211 - Gaudernack , et al. April 18, 2 | 2006-04-18 |
| Peptides App 20050074849 - Gaudernack, Gustav ; et al. | 2005-04-07 |
| Immunogenic .beta.-amyloid peptide Grant 6,861,057 - Gaudernack , et al. March 1, 2 | 2005-03-01 |
| Peptides Grant 6,759,046 - Gaudernack , et al. July 6, 2 | 2004-07-06 |
| Polypeptides App 20040072759 - Gaudernack, Gustav ; et al. | 2004-04-15 |
| Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use App 20030171266 - Gaudernack, Gustav ; et al. | 2003-09-11 |
| Therapeutically useful peptides and peptide fragments Grant 5,961,978 - Gaudernack , et al. October 5, 1 | 1999-10-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 